Cadara Announces Strategic Partnership with Waystar
Cadara has partnered with Waystar to integrate its cloud-based revenue management software with Waystar's AI-powered platform for post-acute healthcare providers.
Stocks · News reference
Truist has increased its price target for Waystar Holding Corp. from $33 to $35 while maintaining a Buy rating.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cadara has partnered with Waystar to integrate its cloud-based revenue management software with Waystar's AI-powered platform for post-acute healthcare providers.
Following the company's third-quarter 2026 earnings report, several financial institutions, including TD Cowen, Evercore ISI, and Deutsche Bank, updated their price targets for Waystar Holding Corp.
Deutsche Bank increased its price target for Waystar Holding Corp. from $39 to $42 while maintaining a Buy rating.
Waystar Holding Corp. announced its third-quarter 2026 financial results, exceeding analyst expectations for revenue and adjusted earnings per share while providing updated full-year guidance.
Waystar and Modern Healthcare released new research highlighting challenges healthcare providers face in preventing payer recoupments.